http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. http://medicalxpress.com/news/2013-05-treatment-blood-cancer.html Cancer Mon, 06 May 2013 08:57:34 EST news287049445 Multiple myeloma is a form of cancer in which the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anaemia, infection and kidney failure. A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, can often be an important treatment option for many patients. Unfortunately, multiple myeloma continues to progress even after a transplant. Within this domain, European researchers have been looking into alternative treatment and in particular at marine extracts and active substances in their search for new methods to fight this disease. http://medicalxpress.com/news/2013-03-treatment-bone-marrow-cancer.html Cancer Thu, 07 Mar 2013 07:20:02 EST news281862054 Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer. http://medicalxpress.com/news/2013-02-compound-high-kidney-cancer.html Cancer Tue, 19 Feb 2013 16:16:17 EST news280512956 A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which patients with multiple myeloma will respond better to certain treatments. The study, titled "Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1," was published in the American Journal of Hematology . http://medicalxpress.com/news/2013-01-aid-treatment-multiple-myeloma-patients.html Cancer Wed, 23 Jan 2013 15:01:11 EST news278175627 Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current standard treatments such as chemotherapy and stem cell transplantation, with an average survival of only about four years. FAIM could thus be a therapeutic target in these patients, as drugs developed to target the molecule could destroy multiple myeloma cells and hence eradicate the cancer. http://medicalxpress.com/news/2012-12-scientists-biomarker-cancer-bone-marrow.html Cancer Thu, 13 Dec 2012 08:25:56 EST news274609544 A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system. http://medicalxpress.com/news/2012-10-harness-immune-stem-cell-transplant.html Immunology Mon, 01 Oct 2012 16:04:31 EST news268326194 A molecule that targets the cell's machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers at Dana-Farber Cancer Institute have found. http://medicalxpress.com/news/2012-09-molecule-effectiveness-drug-resistant-myeloma.html Cancer Mon, 10 Sep 2012 12:00:04 EST news266491091 An early phase multiple myeloma trial has unexpectedly revealed that the drug lenalidomide interacts with another protein in cells that affect its dose level in the body, say researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) who conducted the study. http://medicalxpress.com/news/2011-08-urges-caution-lenalidomide-dosage.html Medications Mon, 08 Aug 2011 16:50:01 EST news232031108